Ritu Baral
Stock Analyst at TD Cowen
(4.98)
# 61
Out of 4,501 analysts
1032
Total ratings
57.2%
Success rate
46.4%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Maintained: Buy | $78 | $42.00 | +85.71% | 25 | Jul 7, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $510 | $324.99 | +56.93% | 27 | Jun 29, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $37 | $26.22 | +41.11% | 65 | Jun 26, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | $306 → $403 | $365.81 | +10.17% | 40 | Jun 18, 2026 | |
| INSM Insmed | Maintained: Buy | $243 | $115.61 | +110.19% | 70 | Jun 16, 2026 | |
| IVA Inventiva | Maintained: Buy | $10 | $4.30 | +132.56% | 6 | Jun 9, 2026 | |
| EPA: IVA Inventiva S.A. | Maintained: Buy | €8.75 | $3.73 | +134.61% | 8 | Jun 8, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $67 | $33.49 | +100.06% | 3 | May 14, 2026 | |
| BNTC Benitec Biopharma | Maintained: Buy | n/a | $13.42 | - | 5 | May 14, 2026 | |
| GHRS GH Research | Maintained: Buy | n/a | $26.51 | - | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $39.63 | - | 23 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.28 | +525.00% | 35 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $13.64 | +112.61% | 21 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.17 | - | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.48 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $45.29 | - | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.52 | - | 24 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $7.37 | +184.94% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $267 | $144.76 | +84.44% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $18.95 | -10.29% | 103 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $644 | $536.70 | +19.99% | 43 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $482 | $298.76 | +61.33% | 99 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $6.87 | +16.45% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.10 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.73 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.10 | - | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.8704 | - | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.50 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.12 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.07 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.37 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $58.25 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.34 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $56.71 | n/a | 5 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $84.85 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.82 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.63 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0111 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.41 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $84.87 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.07 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.74 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.11 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.03 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $3.28 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $199.15 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $14.88 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $8 | $44.22 | n/a | 4 | May 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.0001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.44 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.46 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $10.28 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.61 | n/a | 1 | Feb 21, 2012 |
Vera Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $78
Current: $42.00
Upside: +85.71%
Praxis Precision Medicines
Jun 29, 2026
Maintained: Buy
Price Target: $510
Current: $324.99
Upside: +56.93%
ACADIA Pharmaceuticals
Jun 26, 2026
Maintained: Buy
Price Target: $37
Current: $26.22
Upside: +41.11%
Krystal Biotech
Jun 18, 2026
Maintained: Buy
Price Target: $306 → $403
Current: $365.81
Upside: +10.17%
Insmed
Jun 16, 2026
Maintained: Buy
Price Target: $243
Current: $115.61
Upside: +110.19%
Inventiva
Jun 9, 2026
Maintained: Buy
Price Target: $10
Current: $4.30
Upside: +132.56%
Inventiva S.A.
Jun 8, 2026
Maintained: Buy
Price Target: €8.75
Current: $3.73
Upside: +134.61%
vTv Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $67
Current: $33.49
Upside: +100.06%
Benitec Biopharma
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $13.42
Upside: -
GH Research
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $26.51
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $39.63
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.28
Upside: +525.00%
May 13, 2026
Maintained: Buy
Price Target: $29
Current: $13.64
Upside: +112.61%
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $5.17
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $26.48
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $45.29
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.52
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $21
Current: $7.37
Upside: +184.94%
May 8, 2026
Maintained: Buy
Price Target: $267
Current: $144.76
Upside: +84.44%
May 7, 2026
Maintained: Hold
Price Target: $17
Current: $18.95
Upside: -10.29%
May 6, 2026
Maintained: Buy
Price Target: $644
Current: $536.70
Upside: +19.99%
Apr 30, 2026
Maintained: Buy
Price Target: $482
Current: $298.76
Upside: +61.33%
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $6.87
Upside: +16.45%
Nov 16, 2025
Maintained: Hold
Price Target: n/a
Current: $2.10
Upside: -
Nov 10, 2025
Maintained: Buy
Price Target: n/a
Current: $15.73
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.10
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.8704
Upside: -
Apr 11, 2025
Maintained: Hold
Price Target: n/a
Current: $4.50
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: n/a
Current: $1.12
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $50.07
Upside: n/a
Mar 16, 2020
Maintained: Buy
Price Target: n/a
Current: $34.37
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: n/a
Current: $58.25
Upside: n/a
Feb 24, 2020
Maintained: Buy
Price Target: n/a
Current: $17.34
Upside: n/a
Aug 14, 2019
Rated: Buy
Price Target: n/a
Current: $56.71
Upside: n/a
May 8, 2019
Maintained: Hold
Price Target: n/a
Current: $84.85
Upside: n/a
Jan 6, 2019
Maintained: Buy
Price Target: n/a
Current: $33.82
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $42.63
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.41
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $84.87
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $2.07
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $19.74
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $6.11
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $6.03
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $3.28
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $199.15
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $14.88
Upside: n/a
May 9, 2013
Upgraded: Buy
Price Target: $3 → $8
Current: $44.22
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.0001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.44
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.46
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $10.28
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $5.61
Upside: n/a